Levothyroxine formulations
US9168239B2 · kind B2 · utility
3Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2015 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Mar 13, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A levothyroxine composition includes levothyroxine sodium and mannitol. The composition is a lyophilized solid. The composition may include from 100 to 500 micrograms levothyroxine sodium and from 2 to 4 milligrams mannitol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.